¿Cuáles son? ¿Cómo estudiarlos? | 18 MAR 18
Síndromes neurológicos transitorios
El conocimiento de la etiología de los trastornos neurológicos transitorios y su fenomenología puede ayudar al médico a diagnosticar, clasificar y tratar tales condiciones de manera efectiva
Autor/a: Justin R. Abbatemarco, Alexander D. Rae-Grant Cleve Clin J Med. 2018 Feb;85(2):155-163.
Página 1
1. Vuadens P, Regli F. Drug-induced neurological complications in a hospital cohort. Schweiz Med Wochenschr 1995; 125:1625–1633. French.
2. Hanley K, O’Dowd T, Considine N. A systematic review of vertigo in primary care. Br J Gen Pract 2001; 51:666–671.
3. Brignole M. Diagnosis and treatment of syncope. Heart 2007; 93:130–136.
4. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6:1063–1072.
5. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283–292.
6. Wardlaw JM, Brazzelli M, Chappell FM, et al. ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology 2015; 85:373–380.
7. Nadarajan V, Perry RJ, Johnson J, Werring DJ. Transient ischaemic attacks: mimics and chameleons. Pract Neurol 2014; 14:23–31.
8. Prabhakaran S, Silver AJ, Warrior L, McClenathan B, Lee VH. Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis 2008; 26:630–635.
9. Sorensen AG, Ay H. Transient ischemic attack: definition, diagnosis, and risk stratification. Neuroimaging Clin N Am 2011; 21:303–313.
10. Kimura K, Minematsu K, Yasaka M, Wada K, Yamaguchi T. The duration of symptoms in transient ischemic attack. Neurology 1999; 52:976–980.
11. Lewandowski CA, Rao CP, Silver B. Transient ischemic attack: definitions and clinical presentations. Ann Emerg Med 2008; 52:S7–S16.
12. Easton JD, Saver JL, Albers GW, et al; American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40:2276–2293.
13. Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA 2007; 298:2877–2885.
14. van Rooij FG, Vermeer SE, Goraj BM, et al. Diffusion-weighted imaging in transient neurological attacks. Ann Neurol 2015; 78:1005–1010.
15. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol 1995; 15:175–182.
16. Viana M, Sprenger T, Andelova M, Goadsby PJ. The typical duration of migraine aura: a systematic review. Cephalalgia 2013; 33:483–
490.
17. Young WB, Gangal KS, Aponte RJ, Kaiser RS. Migraine with unilatera motor symptoms: a case-control study. J Neurol Neurosurg Psychiatry 2007; 78:600–604.
18. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125:1379–1391.
19. Buzzi MG, Cologno D, Formisano R, Rossi P. Prodromes and the early phase of the migraine attack: therapeutic relevance. Funct Neurol 2005; 20:179–183.
20. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004; 44:865–872.
21. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003; 60:935–940.
22. Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am 2001; 85:911–941.
23. Naeije G, Gaspard N, Legros B, Mavroudakis N, Pandolfo M. Transient CNS deficits and migrainous auras in individuals without a history of headache. Headache 2014; 54:493–499.
24. Tuna MA, Mehta Z, Rothwell PM; Stroke Prevention Research Unit, Neuroscience Department, John Radcliffe Hospital, Oxford University. Stroke risk after a first late–onset migraine–like transient neurological attack (TNA): Oxford vascular study TNA cohort. J Neurol Neurosurg Psychiatry 2013; 84:e2.
25. Fisher CM. Late-life migraine accompaniments—further experience. Stroke 1986; 17:1033–1042.
26. Walker HK, Hall WD, Hurst JW. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston, MA: Butterworths; 1990.
27. Wyllie E, Rothner A
2. Hanley K, O’Dowd T, Considine N. A systematic review of vertigo in primary care. Br J Gen Pract 2001; 51:666–671.
3. Brignole M. Diagnosis and treatment of syncope. Heart 2007; 93:130–136.
4. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6:1063–1072.
5. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283–292.
6. Wardlaw JM, Brazzelli M, Chappell FM, et al. ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology 2015; 85:373–380.
7. Nadarajan V, Perry RJ, Johnson J, Werring DJ. Transient ischaemic attacks: mimics and chameleons. Pract Neurol 2014; 14:23–31.
8. Prabhakaran S, Silver AJ, Warrior L, McClenathan B, Lee VH. Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis 2008; 26:630–635.
9. Sorensen AG, Ay H. Transient ischemic attack: definition, diagnosis, and risk stratification. Neuroimaging Clin N Am 2011; 21:303–313.
10. Kimura K, Minematsu K, Yasaka M, Wada K, Yamaguchi T. The duration of symptoms in transient ischemic attack. Neurology 1999; 52:976–980.
11. Lewandowski CA, Rao CP, Silver B. Transient ischemic attack: definitions and clinical presentations. Ann Emerg Med 2008; 52:S7–S16.
12. Easton JD, Saver JL, Albers GW, et al; American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40:2276–2293.
13. Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA 2007; 298:2877–2885.
14. van Rooij FG, Vermeer SE, Goraj BM, et al. Diffusion-weighted imaging in transient neurological attacks. Ann Neurol 2015; 78:1005–1010.
15. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol 1995; 15:175–182.
16. Viana M, Sprenger T, Andelova M, Goadsby PJ. The typical duration of migraine aura: a systematic review. Cephalalgia 2013; 33:483–
490.
17. Young WB, Gangal KS, Aponte RJ, Kaiser RS. Migraine with unilatera motor symptoms: a case-control study. J Neurol Neurosurg Psychiatry 2007; 78:600–604.
18. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125:1379–1391.
19. Buzzi MG, Cologno D, Formisano R, Rossi P. Prodromes and the early phase of the migraine attack: therapeutic relevance. Funct Neurol 2005; 20:179–183.
20. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004; 44:865–872.
21. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003; 60:935–940.
22. Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am 2001; 85:911–941.
23. Naeije G, Gaspard N, Legros B, Mavroudakis N, Pandolfo M. Transient CNS deficits and migrainous auras in individuals without a history of headache. Headache 2014; 54:493–499.
24. Tuna MA, Mehta Z, Rothwell PM; Stroke Prevention Research Unit, Neuroscience Department, John Radcliffe Hospital, Oxford University. Stroke risk after a first late–onset migraine–like transient neurological attack (TNA): Oxford vascular study TNA cohort. J Neurol Neurosurg Psychiatry 2013; 84:e2.
25. Fisher CM. Late-life migraine accompaniments—further experience. Stroke 1986; 17:1033–1042.
26. Walker HK, Hall WD, Hurst JW. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston, MA: Butterworths; 1990.
27. Wyllie E, Rothner A
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
CONTENIDOS RELACIONADOS
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024